Cambridge Investment Research Advisors Inc. raised its position in shares of Equifax Inc. (NYSE:EFX) by 271.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,698 shares of the credit services provider’s stock after buying an additional 4,894 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Equifax were worth $624,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc lifted its holdings in Equifax by 0.5% in the 3rd quarter. Vanguard Group Inc now owns 12,212,967 shares of the credit services provider’s stock valued at $1,594,647,000 after purchasing an additional 65,505 shares in the last quarter. Capital International Investors lifted its holdings in Equifax by 2.3% in the 3rd quarter. Capital International Investors now owns 6,475,374 shares of the credit services provider’s stock valued at $845,490,000 after purchasing an additional 148,440 shares in the last quarter. Cantillon Capital Management LLC lifted its holdings in Equifax by 0.7% in the 4th quarter. Cantillon Capital Management LLC now owns 2,421,681 shares of the credit services provider’s stock valued at $225,531,000 after purchasing an additional 15,943 shares in the last quarter. Senator Investment Group LP lifted its holdings in Equifax by 115.0% in the 3rd quarter. Senator Investment Group LP now owns 2,150,000 shares of the credit services provider’s stock valued at $280,726,000 after purchasing an additional 1,150,000 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in Equifax by 1.2% in the 3rd quarter. Mackenzie Financial Corp now owns 1,913,405 shares of the credit services provider’s stock valued at $249,833,000 after purchasing an additional 22,228 shares in the last quarter. 93.39% of the stock is owned by institutional investors and hedge funds.
NYSE EFX opened at $111.02 on Friday. The stock has a market capitalization of $13.40 billion, a price-to-earnings ratio of 19.17, a PEG ratio of 2.30 and a beta of 1.23. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.09 and a quick ratio of 1.09. Equifax Inc. has a 1-year low of $88.68 and a 1-year high of $138.69.
Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, February 20th. The credit services provider reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.32 by $0.06. The business had revenue of $835.30 million during the quarter, compared to analysts’ expectations of $841.49 million. Equifax had a return on equity of 21.58% and a net margin of 8.78%. The business’s quarterly revenue was down .4% compared to the same quarter last year. During the same quarter last year, the business posted $1.39 EPS. On average, sell-side analysts forecast that Equifax Inc. will post 5.67 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Tuesday, March 12th will be paid a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Monday, March 11th. Equifax’s payout ratio is presently 26.94%.
A number of brokerages have issued reports on EFX. Deutsche Bank cut their target price on Equifax from $128.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, January 14th. Morgan Stanley cut their target price on Equifax from $115.00 to $104.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 8th. TD Securities reaffirmed an “average” rating on shares of Equifax in a research note on Monday, January 7th. Robert W. Baird cut their target price on Equifax from $115.00 to $109.00 and set an “outperform” rating for the company in a research note on Wednesday, December 19th. Finally, Credit Suisse Group started coverage on Equifax in a research report on Friday, December 7th. They set an “outperform” rating and a $125.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company’s stock. Equifax presently has a consensus rating of “Hold” and an average target price of $119.45.
TRADEMARK VIOLATION WARNING: This report was originally published by Fairfield Current and is owned by of Fairfield Current. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://www.fairfieldcurrent.com/news/2019/03/17/equifax-inc-efx-holdings-increased-by-cambridge-investment-research-advisors-inc.html.
Equifax Company Profile
Equifax Inc provides information solutions and human resources business process outsourcing services for businesses, governments, and consumers. The company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions, and Global Consumer Solutions. The USIS segment offers consumer and commercial information services, such as credit information and credit scoring, credit modeling and portfolio analytics, locate, fraud detection and prevention, identity verification, and other consulting; mortgage loan origination information; financial marketing; and identity management services.
Further Reading: What is the Quick Ratio?
Receive News & Ratings for Equifax Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Equifax and related companies with MarketBeat.com’s FREE daily email newsletter.